Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The 2018 European Lung Cancer Congress (ELCC), held in Geneva, Switzerland, took place on the 11–14 April. ELCC 2018 brought together leading researchers from around the world, who showcased the latest research and developments in lung cancer.
Highlights from this year’s meeting include key results from several clinical trials investigating non-small cell lung cancer (NSCLC), including ALEX and PACIFIC, expert insights into our increased understanding of the PD-L1 as a predictive biomarker, and novel combinations therapies with the potential to transform outcomes.
ELCC 2018
The 2018 European Lung Cancer Congress (ELCC), held in Geneva, Switzerland, took place on the 11–14 April. ELCC 2018 brought together leading researchers from around the world, who showcased the latest research and developments in lung cancer.
Highlights from this year’s meeting include key results from several clinical trials investigating non-small cell lung cancer (NSCLC), including ALEX and PACIFIC, expert insights into our increased understanding of the PD-L1 as a predictive biomarker, and novel combinations therapies with the potential to transform outcomes.
